The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease

Overview of attention for article published in Current Cardiology Reports, July 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#29 of 1,003)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 294,852 followers.

RT @drjohnm: Previewing #acc21 and I wonder why the @PCORI sponsored ADAPTABLE trial protocol is published in a paywalled for-profit journa…

RT @drjohnm: Previewing #acc21 and I wonder why the @PCORI sponsored ADAPTABLE trial protocol is published in a paywalled for-profit journa…

RT @texhern: We published the protocol here at the beginning and received comments from the public incorporated into the design/revision…

RT @texhern: We published the protocol here at the beginning and received comments from the public incorporated into the design/revision…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.